abstract |
The present invention relates to a vaccine comprising a polypeptide or protein selected from the group consisting ofp54, Q4Q8Z6, Q4Q6L9, Q4QHT2, E9AE98, or an immunologically effective fragment thereof, for use in the prevention or treatment of leishmaniasis. The invention further relates to a pharmaceutical composition comprising such a vaccine. |